Desvenlafaxine Extended Release Tablets – Next-Generation SNRI for Depression & Mood Disorders.
DESLAR 50: Desvenlafaxine 50 mg ER is a potent SNRI (serotonin-norepinephrine reuptake inhibitor), approved for the treatment of major depressive disorder. It enhances neurotransmitter activity in the CNS to improve mood, motivation, and overall functioning.
Recommended BY Specialists:
General Physician: It is mainly used to treat the disease associated with initiating treatment for mild to moderate depression
Psychiatrist: It is preferred to treat the disease associated with the Primary specialist Major depressive disorder
Key Benefits of Desvenlafaxine Extended Release Tablets – DESLAR 50
Sustained Symptom Relief – Extended-release formulation ensures stable plasma levels, reducing dosing frequency and minimizing mood fluctuations.
Dual-Action Antidepressant – Inhibits both serotonin and norepinephrine reuptake, improving energy, mood, and cognitive function in major depressive disorder (MDD).
Well-Tolerated with Fewer Side Effects – Lower risk of sexual dysfunction, weight gain, or sedation compared to older antidepressants; preferred in long-term therapy.
Indications:
Major Depressive Disorder (MDD)
Anxiety Disorders
Menopausal Vasomotor Symptoms
Neuropathic Pain (Off-label use)